Adrenal carcinoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Category)
 
(9 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Pathophysiology==
==Pathophysiology==
Adrenal tumors are often not biopsied prior to surgery, so diagnosis is confirmed on examination of the surgical specimen by a [[anatomical pathology|pathologist]]. Grossly, adrenocortical carcinomas are often large, with a tan-yellow cut surface, and areas of [[hemorrhage]] and [[necrosis]]. On [[histopathology|microscopic examination]], the tumor usually displays sheets of atypical cells with some resemblance to the cells of the normal [[adrenal cortex]]. The presence of [[invasion]] and [[mitosis|mitotic activity]] help differentiate small cancers from [[adrenocortical adenoma]]s.<ref name="Weidner's">{{cite book |author=Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) |title=Modern Surgical Pathology (2 Volume Set) |publisher=W B Saunders |location=London |year= |pages= |isbn=0-7216-7253-1 |oclc= |doi=}}</ref>
===Pathology===
===Microscopic Pathology===
Adrenal tumors are often not biopsied prior to surgery, so diagnosis is confirmed on examination of the surgical specimen by a [[anatomical pathology|pathologist]].
Shown below is a micrograph of an adrenocortical carcinoma (left of image - dark blue) and the adrenal cortex it arose from (right-top of image - pink/light blue). Benign adrenal medulla is present (right-middle of image - gray/blue). H&E stain.
 
[[Image: 800px-Adrenal_cortical_carcinoma_-_low_mag.jpg‎|400px]]
 
===Genetics===
The main etiologic factor of adrenocortical cancer is unknown. Families with [[Li-Fraumeni syndrome]] have increased risk. The [[p53]], [[retinoblastoma protein]] (RB) [[tumor suppressor gene]]s located on chromosomes 17p, 13q respectively,  may be changed. The genes h19, insulin-like growth factor II ([[IGF-II]]), p57<sup>kip2</sup> are important for fetal growth and development. They are located on chromosome 11p. Expression of the h19 gene is markedly reduced in both nonfunctioning and functioning adrenal cortical carcinomas, especially in tumors producing [[cortisol]] and [[aldosterone]]. There is also a loss of activity of the p57<small>kip2</small> gene product in [[virilizing]] adenomas and adrenal cortical carcinomas. In contrast, IGF-II gene expression has been shown to be high in adrenal cortical carcinomas. Finally, c-myc gene expression is relatively high in neoplasms, and it is often linked to poor prognosis.<ref>{{cite book |author=Kufe D |editor=Benedict RC, Holland JF |title=Cancer medicine |publisher=B.C. Decker |location=Hamilton, Ont |year=2000 |edition=5th |isbn=1-55009-113-1 |oclc=156944448 }}</ref>


==References==
==References==
Line 16: Line 10:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Oncology]]
[[Category:Needs Overview]]
[[Category:Needs Overview]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Endocrinology]]
[[Category:Surgery]]

Latest revision as of 02:23, 24 October 2017

Adrenal Carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenal Carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adrenal carcinoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenal carcinoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenal carcinoma pathophysiology

CDC on Adrenal carcinoma pathophysiology

Adrenal carcinoma pathophysiology in the news

Blogs on Adrenal carcinoma pathophysiology

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Adrenal carcinoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pathophysiology

Pathology

Adrenal tumors are often not biopsied prior to surgery, so diagnosis is confirmed on examination of the surgical specimen by a pathologist.

References

Template:WH Template:WS